Merck Animal Health (known as MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, announced today that it has donated about US $30,000 (¥2,3 million) to three veterinary and farmer associations in Japan to support recovery of the Japanese animal sector following the earthquake and tsunami as well as its consequences that have struck the country in March 2011. The disaster had an immense impact on the healthcare situation of the pet, pig and livestock sectors.

Merck Animal Health has made the donation available to three important stakeholders in the Japanese animal sector for further coordination, being the Japan Veterinary Medical Association, the Japan Pork Producers Association and the Regional Livestock Industry Promotional Council.

The Japan Veterinary Medical Association works for the restoration of the veterinary care supply at the afflicted area. The donation will be used for support to and re-establishment of the pet shelter and veterinary facilities. The Japanese Pork Producers Association and the Japanese Livestock Industry Promotion Council will allocate the support based on the degree of damage in the afflicted region and the funds will also be used to restore businesses which were severely damaged due to ruined barns, feed factories, and the evacuate order away from the disaster area.

“After the international community has provided support during the acute phase of the disaster, for example via shipment of emergency supplies of veterinary medicines and the activities of first responders, it is equally important to continue to support the Japanese animal health and associated sector in order to accelerate the recovery of this economically important category. We trust that via this donation we can contribute to the Japanese society, enabling them to overcome this difficult situation,” said Leopoldo Nanni, Vice President, Head of Asia-Pacific-Sub Sahara Africa at Merck Animal Health.

The March 2011 earthquake and tsunami that hit Japan have caused widespread devastation that affected many of the country’s agricultural sector. The nuclear crisis that followed, and the subsequent detection of radioactive contamination in the food chain, further raised concerns about the safety of Japan’s food production systems. The affected coastal prefectures are important to Japan’s food-producing sector; before the disaster (based on 2007 USDA figures*) the region was responsible for approximately 17 percent of total national livestock production, representing an annual economic output value of approximately US $5.5 billion (¥425 billion). Moreover, as many people still live in evacuation centers, there is an ongoing need for pet shelter facilities.

Reference

* Johnson R. Japan’s 2011 Earthquake and Tsunami: Food and Agricultural Implications. Congressional Research Service Report for Congress, May 18, 2011.

About Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. Merck Animal Health offers veterinarians, farmers, pet owners and governments the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com.

Merck & Co., Inc.

Merck & Co., Inc.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

More from Merck & Co., Inc.